FDA advisory panel to meet next month on Merck COVID pill

The FDA will have its outside experts meet late next month to discuss the experimental antiviral pill designed to treat COVID from Merck.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting